Alexander Lesokhin

Credentials: · · ·

History

Nivolumab plus ipilimumab in advanced melanoma
New England Journal of Medicine · 2013 · 3,387 citations
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
New England Journal of Medicine · 2015 · 2,937 citations
Immunologic correlates of the abscopal effect in a patient with melanoma
Case report · New England Journal of Medicine · 2012 · 1,720 citations

A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2026–2029
A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2021–2026
A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma
Principal investigator · Withdrawn · Phase 1
Memorial Sloan Kettering Cancer Center
2017–2020
Lenalidomide Maintenance in Plasma Cell Myeloma
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2015–2026